Email Us Here

Eleison Pharmaceuticals Announces That ILC Has Been Granted Orphan Drug Designation in Europe for the Treatment of Osteosarcoma

Eleison Pharmaceuticals today announced that the European Commission has granted Orphan Drug Designation to ILC (Inhaled Lipid-complexed Cisplatin) for the treatment of osteosarcoma.